» Articles » PMID: 39234773

Glymphatic System and Psychiatric Disorders: A Rapid Comprehensive Scoping Review

Abstract

Background: Since discovering the glymphatic system, there has been a looming interest in exploring its relationship with psychiatric disorders. Recently, increasing evidence suggests an involvement of the glymphatic system in the pathophysiology of psychiatric disorders. However, clear data are still lacking. In this context, this rapid comprehensive PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) scoping review aims to identify and analyze current evidence about the relation between the glymphatic system and psychiatric disorders.

Methods: We conducted a comprehensive review of the literature and then proceeded to discuss the findings narratively. Tables were then constructed and articles were sorted according to authors, year, title, location of study, sample size, psychiatric disorder, the aim of the study, principal findings, implications.

Results: Twenty papers were identified as eligible, among which 2 articles on Schizophrenia, 1 on Autism Spectrum Disorders, 2 on Depression, 1 on Depression and Trauma-related Disorders, 1 on Depression and Anxiety, 2 on Anxiety and Sleep Disorders, 8 on Sleep Disorders, 2 on Alcohol use disorder and 1 on Cocaine Use Disorder.

Conclusion: This review suggests a correlation between the glymphatic system and several psychiatric disorders: Schizophrenia, Depression, Anxiety Disorders, Sleep Disorders, Alcohol Use Disorder, Cocaine Use Disorder, Trauma-Related Disorders, and Autism Spectrum Disorders. Impairment of the glymphatic system could play a role in Trauma-Related Disorders, Alcohol Use Disorders, Cocaine Use Disorders, Sleep Disorders, Depression, and Autism Spectrum Disorders. It is important to implement research on this topic and adopt standardized markers and radio diagnostic tools.

Citing Articles

Cerebral Small Vessel Disease Outperforms Brain Atrophy as an Imaging Biomarker in Diabetic Retinopathy.

Shen X, Zhang W, Li X, Zhang X, Li Q, Wu M J Diabetes. 2025; 17(2):e70058.

PMID: 39968694 PMC: 11836613. DOI: 10.1111/1753-0407.70058.

References
1.
van Veluw S, Hou S, Calvo-Rodriguez M, Arbel-Ornath M, Snyder A, Frosch M . Vasomotion as a Driving Force for Paravascular Clearance in the Awake Mouse Brain. Neuron. 2019; 105(3):549-561.e5. PMC: 7028316. DOI: 10.1016/j.neuron.2019.10.033. View

2.
Siow T, Toh C, Hsu J, Liu G, Lee S, Chen N . Association of Sleep, Neuropsychological Performance, and Gray Matter Volume With Glymphatic Function in Community-Dwelling Older Adults. Neurology. 2021; 98(8):e829-e838. DOI: 10.1212/WNL.0000000000013215. View

3.
Schubert J, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B . Dynamic C-PiB PET Shows Cerebrospinal Fluid Flow Alterations in Alzheimer Disease and Multiple Sclerosis. J Nucl Med. 2019; 60(10):1452-1460. PMC: 6785797. DOI: 10.2967/jnumed.118.223834. View

4.
Lundgaard I, Li B, Xie L, Kang H, Sanggaard S, Haswell J . Direct neuronal glucose uptake heralds activity-dependent increases in cerebral metabolism. Nat Commun. 2015; 6:6807. PMC: 4410436. DOI: 10.1038/ncomms7807. View

5.
Louveau A, Herz J, Alme M, Salvador A, Dong M, Viar K . CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018; 21(10):1380-1391. PMC: 6214619. DOI: 10.1038/s41593-018-0227-9. View